Pfizer (PFE) Tops Q1 EPS by 2c, Revenues Miss; Reaffirmed Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts quarterly revenue above estimates, shares rise
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
PFIZER REPORTS FIRST-QUARTER 2018 RESULTS
May 1, 2018 6:45 AM EDTFirst-Quarter 2018 Revenues of $12.9 Billion First-Quarter 2018 Reported Diluted EPS(1) of $0.59, Adjusted Diluted EPS(2) of $0.77 Reaffirmed All Components of 2018 Financial Guidance
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2018 and reaffirmed all components of 2018 financial guidance.
Results for the first quarter of 2018 and 2017(3) are summarized below.
OVERALL RESULTS Â($ in millions, except per share amounts)
 First-Quarter 2018   2017   Change Revenues  $  12,906    $  12,779    1% Reported Net Income(1) 3,561 3,121 14% Reported Diluted EPS(1) 0.59 0.51 15% Adjusted Income(2) 4,668 4,192 11% Adjusted Diluted EPS(2) 0.77 0.69 12% ÂREVENUES
 ... More